MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 3 filers reported holding MARKER THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,562 | -28.8% | 13,390 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 13,390 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -16.7% | 13,390 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -53.8% | 13,390 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -40.9% | 13,390 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | -40.5% | 13,390 | 0.0% | 0.00% | – |
| Q2 2021 | $37,000 | +23.3% | 13,390 | 0.0% | 0.00% | – |
| Q1 2021 | $30,000 | +57.9% | 13,390 | 0.0% | 0.00% | – |
| Q4 2020 | $19,000 | -9.5% | 13,390 | 0.0% | 0.00% | – |
| Q3 2020 | $21,000 | -22.2% | 13,390 | 0.0% | 0.00% | – |
| Q2 2020 | $27,000 | +3.8% | 13,390 | 0.0% | 0.00% | – |
| Q1 2020 | $26,000 | -31.6% | 13,390 | 0.0% | 0.00% | – |
| Q4 2019 | $38,000 | -44.9% | 13,390 | 0.0% | 0.00% | – |
| Q3 2019 | $69,000 | -34.9% | 13,390 | 0.0% | 0.00% | – |
| Q2 2019 | $106,000 | +20.5% | 13,390 | 0.0% | 0.00% | – |
| Q1 2019 | $88,000 | – | 13,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AR ASSET MANAGEMENT INC | 70,700 | $321 | 0.09% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |